口服多西环素治疗早期神经梅毒的临床与血清学结局
结果显示两组在血清学反应和症状完全缓解率上相似,所有患者均获得血清学反应,91%在治疗结束后30天症状完全缓解。作者认为需随机对照试验证实多西环素治疗早期神经梅毒的有效性。
要点
- 口服多西环素与肌注普鲁卡因青霉素G治疗早期神经梅毒的临床和血清学结局相似。
- 所有患者均获得血清学反应,91%在治疗结束后30天症状完全缓解。
- 多西环素可作为不宜使用青霉素方案患者的替代选择,但需随机对照试验验证。
核心结论
- 口服多西环素与肌注普鲁卡因青霉素G治疗早期神经梅毒的临床和血清学结局相似。
主要发现
- 71%接受肌注普鲁卡因青霉素G治疗,18%接受口服多西环素治疗。
- 所有患者均获得血清学反应,91%在治疗结束后30天报告症状完全缓解。
- 普鲁卡因青霉素G组与多西环素组的临床和血清学反应率及血清转归率相似。
临床怎么用
- 对于不宜使用青霉素方案的早期神经梅毒患者,可考虑口服多西环素作为替代治疗。
局限性
- 需随机对照试验确立多西环素治疗早期神经梅毒的有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Penicillin-based antibiotic treatment for syphilis infection with CNS involvement (early neurosyphilis) is not always a suitable treatment option. We compared outcomes of patients diagnosed with early neurosyphilis and treated with doxycycline or procaine G penicillin. METHODS: Serological and clinical outcomes were analysed in patients diagnosed with early neurosyphilis between January 2015 and October 2019 at 56 Dean Street, a combined sexual health and HIV service based in London, UK. Acute onset of CNS, ocular and/or otic symptomatology and a documented seroconverting syphilis serology or a >4-fold increase in rapid plasma reagin ('RPR)' test titre within the previous 12 months were criteria used to define a case. Mann-Whitney U-test and χ2 tests were used to test distributions between baseline characteristics and outcomes according to treatment administered. RESULTS: Eighty-seven patients were included: median age = 35 years (IQR = 31-45), 98% MSM, 79% white ethnicity, 53% HIV-1 positive and 40% previously diagnosed with syphilis at any stage. They were treated exclusively with either intramuscular (IM) procaine G penicillin (71%) or oral doxycycline (18%). Patients received doxycycline treatment over a penicillin-based regimen due to IM treatment declined (31%), inability to attend for IM injections (31%) or penicillin allergy (19%). Serological response was achieved by all patients; 91% reported full symptom resolution at 30 days from end of treatment. Similar rates of clinical and serological response and seroreversion were observed in the groups treated with procaine G penicillin versus doxycycline. CONCLUSIONS: The clinical and serological outcomes seen with penicillin-based versus doxycycline treatments were similar. A randomized controlled trial is needed to establish the effectiveness of doxycycline in the treatment of early neurosyphilis.
引用
- Girometti N, Junejo MH, Nugent D, et al. Clinical and serological outcomes in patients treated with oral doxycycline for early neurosyphilis. J Antimicrob Chemother. 2021. PMID: 33783506. doi:10.1093/jac/dkab100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。